Young & Partners
Young & Partners is a New York-based boutique investment bank founded in 1996 that provides M&A advisory, financial advisory, capital raising, and strategy consulting exclusively to chemical and life science companies, supported by proprietary trade publications, industry portals, and annual conferences.
- Company typePrivate
- Founded1996
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Young & Partners does
Young & Partners is a boutique investment banking firm founded in 1996 and headquartered at 535 Fifth Avenue, New York, that provides M&A advisory, financial advisory, capital raising, and strategy consulting services exclusively to companies in the chemicals and life sciences sectors — spanning chemicals, pharmaceuticals, biotechnology, medical devices, and CRO/CDMO sub-verticals. The firm is structured as a private LLC, operates with 11–50 employees, and is led by founder Peter Young (President, CEO and Managing Director), with additional senior coverage from Managing Director Stephen Floyd, CMO/Managing Partner Todd Bassett, and dedicated sector author Jonathan Choi. Its revenue model is professional services — primarily transaction-based advisory fees on M&A, divestitures, and capital raises — with no publicly disclosed pricing or revenue figures.
The firm operates a platform-plus-services model in which the core advisory practice is supported by a proprietary content and events infrastructure: recurring bylined analyses published in ICIS Chemical Business, Pharmaceutical Executive, and Chemical Week; three dedicated industry portals (ChemicalIndustry.com, PharmaIndustry.com, MedicalDeviceIndustry.com); the Young & Partners Forum webcast; and annual industry events including the Chemical Conference and the Pharmaceutical Executive / Life Science Summit. Geographic reach is anchored in North America, with documented cross-border M&A coverage in Latin America established through a 2011 joint venture with Brazilian investment bank Virtus Br. There is no evidence of proprietary technology products, APIs, or AI/ML capabilities; the firm's differentiation rests on sector specialization, founder-led client relationships, and thought-leadership distribution rather than on technology assets.
Young & Partners firmographics
Firmographics- Name
- Young & Partners
- Legal name
- Young & Partners LLC
- Website
- https://youngandpartners.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Young & Partners is a New York-based boutique investment bank founded in 1996 that provides M&A advisory, financial advisory, capital raising, and strategy consulting exclusively to chemical and life science companies, supported by proprietary trade publications, industry portals, and annual conferences.
- Ownership category
- akta.pro rank
Young & Partners industry classification
Industry- Product category
- Specialty Investment Banking Advisory
- NAICS
- Investment Banking and Securities Intermediation (523150), Management, Scientific, and Technical Consulting Services (5416)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Industry-Specialist / Sector-Focused M&A Advisory (FSAEAGAJ)
- akta.pro secondary industries
- Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC), Corporate Finance & Capital Advisory (BPAHADAB), Strategy & Corporate Development Consulting (BPAHACAA)
Keywords
Where Young & Partners is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Young & Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Investment Banking Advisory: M&A advisory, financial advisory, and capital raising services for chemical and life science companies
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Young & Partners product offering
Product offeringCore offering
Young & Partners is a boutique investment bank providing M&A advisory, strategy consulting, financial advisory, and capital raising services to chemical, pharmaceutical, biotechnology, medical device, and CRO/CDMO companies. The firm pairs its advisory practice with proprietary industry analyses, annual conferences, and industry portal websites that support client development within the chemical and life science verticals.
Product overview
Young & Partners is a specialized investment banking firm focused on the chemical and life science sectors. The firm operates a platform-plus-services model, offering core M&A advisory, strategy consulting, financial advisory, and capital raising services, complemented by proprietary research publications (Pharmaceutical Executive articles, ICIS Chemical Business analyses, Chemical Week commentary), annual industry conferences (Chemical Conferences, Life Science/Pharmaceutical Executive Summits), and dedicated industry portals (ChemicalIndustry.com, PharmaIndustry.com, MedicalDeviceIndustry.com). The publications, conferences, and portals serve as thought leadership and client development tools that support the advisory business.
Differentiator
Problem solved
Functional benefit
Brands
- Young & Partners Forum: Webcast and discussion platform hosted by Young & Partners for industry professionals
Products and services
- Investment Banking Advisory Services Boutique investment banking offering that includes M&A advisory, strategy consulting, financial advisory, and capital raising services for chemical, pharmaceutical, biotechnology, medical device, and CRO/CDMO companies. Engagements are executed directly by senior bankers for corporate executives and owners.
Companies that use Young & Partners
Customer profileSegments2 records
Ideal customer profiles2 records
Young & Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Young & Partners partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Virtus BrcoreYoung & Partners entered into a Brazilian cross-border M&A joint venture with Virtus Br, one of the leading Brazilian investment banks, to expand their cross-border Brazilian Mergers and Acquisition Services in Chemicals and Life Sciences. This partnership enabled Young & Partners to better serve clients seeking M&A transactions involving Brazil.
Scale indicators2 records
Recent moves7 records
Expansion highlights5 records
Young & Partners competitors and assessment
Company assessmentBroad incumbents
- Stifel Financial: Large diversified investment bank with active Healthcare and Specialty Chemicals coverage, providing M&A and capital markets services at a scale that competes against Young & Partners on mid-market mandates.
- Jefferies: Full-service global investment bank with a long-standing specialty in chemicals and life sciences investment banking, offering financing capabilities and equity research Young & Partners cannot match.
- Houlihan Lokey: Larger global investment bank with active Chemicals and Life Sciences coverage groups providing M&A and capital raising services - overlaps on sector specialization but at materially greater scale and broader product offering.
Direct peers
- Covington Associates: Middle-market M&A advisory firm with a dedicated Healthcare and Life Sciences practice, comparable boutique positioning serving transaction needs in pharma, biotech, and medical devices.
- Locust Walk: Specialized life sciences advisory firm offering M&A and strategic partnering services to biopharma and medtech clients, mirroring Young & Partners' boutique life sciences advisory model.
- Lincoln International: Global mid-market investment bank with dedicated Chemicals and Life Sciences practices providing M&A advisory and capital raising - directly comparable boutique-to-mid-market positioning and sector focus to Young & Partners.
- Outcome Capital: Boutique life sciences advisory firm providing strategic and financial advisory to pharma, biotech, and medtech companies - directly comparable specialty M&A positioning on the life sciences side of Young & Partners' practice.
- Harris Williams: Middle-market M&A advisor with dedicated Chemicals and Life Sciences groups, comparable in boutique scale and sector specialization for sell-side and buy-side advisory services.
- MTS Health Partners: Boutique M&A advisory firm exclusively serving healthcare and life sciences companies, comparable to Young & Partners in scale and sector-specialist positioning on the life sciences side.
Emerging players
- PharmaVentures: Specialized pharma and biotech advisory and transaction firm supporting licensing, M&A, and dealmaking, overlapping with Young & Partners' pharmaceutical M&A and capital raising offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks4 records
Key highlights6 records
Customer concentration
Young & Partners social profiles
Digital presenceYoung & Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Young & Partners leadership team
Management profileNumber of profiles
Profiles4 records
Young & Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Young & Partners M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Young & Partners
What does Young & Partners do?
Young & Partners is a boutique investment bank providing M&A advisory, strategy consulting, financial advisory, and capital raising services to chemical, pharmaceutical, biotechnology, medical device, and CRO/CDMO companies. The firm pairs its advisory practice with proprietary industry analyses, annual conferences, and industry portal websites that support client development within the chemical and life science verticals.
Is Young & Partners a public or private company?
Young & Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Young & Partners founded?
Young & Partners was founded in 1996. It employs 11 to 50 people.
Where is Young & Partners based?
Young & Partners is headquartered in New York, United States, in the North America region.
How does Young & Partners make money?
One revenue line is on record: investment Banking Advisory.
Who are Young & Partners's main competitors?
Broad incumbents on record are Stifel Financial, Jefferies and Houlihan Lokey. Direct peers are Covington Associates, Locust Walk, Lincoln International, Outcome Capital, Harris Williams and MTS Health Partners. PharmaVentures is listed as an emerging player.
Does Young & Partners have an API?
No public API is recorded for Young & Partners.
What industry is Young & Partners in?
Young & Partners's product category is Specialty Investment Banking Advisory. Its primary akta.pro industry code is FSAEAGAJ, Industry-Specialist / Sector-Focused M&A Advisory, with a secondary code of FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked). Its NAICS code is 523150 and its SIC code is 6211.